When was microMend founded?

microMend was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is microMend located?

microMend is headquartered in Seattle, United States.

How many employees does microMend have?

As of Aug 31, 2026, the latest employee count at microMend is 11.

Is microMend a funded company?

microMend is a funded company, having raised a total of $3.41M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 28, 2020.

When was the latest funding round of microMend?

microMend's latest funding was a $***** Series B round on Dec 07, 2021, with participation from 0 investor. Its primary sector is Wound Care. In United States, the Wound Care sector has seen $83.4M in funding in 2026 to date.

Where does microMend rank among its competitors?

microMend ranks 6th amongst 35 active competitors, of which 8 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Medicud, which secured an undisclosed amount in Apr, 2025.

Who are the top competitors of microMend?

microMend's top competitors include Kerecis, Aroa Biosurgery and Biolife. Among them, Medicud secured the most recent funding round in April, 2025.

microMend - 2026 Company Profile, Funding & Competitors

microMend is a series B company based in Seattle (United States), founded in 2017. It operates as a Provider of solutions for the treatment of dermatological disorders. microMend has raised $3.41M in funding. The company has 35 active competitors, including 8 funded and 8 that have exited. Its top competitors include companies like Kerecis, Aroa Biosurgery and Biolife.

Company Details

MicroMend is a provider of solutions for the treatment of dermatological disorders. The company's unique wound closure device uses tiny staples that poke into the skin on either side of a wound and is applied over a cut like a traditional butterfly bandage. The process is painless and can heal wounds up to three times faster than those closed with traditional sutures.

Website: www.micromendskinclosure.com
Social
Email ID: *****@kitotechmedical.com
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

2017

Location

Seattle, United States

Stage

Series B

Total Funding

$3.41M in 3 rounds

Latest Funding Round

Series B, Dec 07, 2021, $*****

Investors

Denniston Family Office & 4 more

Ranked

6^th among 35 active competitors

Employee Count

11 as on Aug 31, 2026

Similar Companies

Kerecis & 36 more

View microMend's full profile

microMend has raised a total funding of $3.41M over 3 rounds. Its first funding round was on Aug 28, 2020. microMend has 5 institutional investors.

Here is the list of recent funding rounds of microMend:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 07, 2021	2552527	Series B	9227157	4528745	2909023	2323544
Nov 20, 2020	8034960	Seed	8440705	2576276	4908213	9940803
Aug 28, 2020	3737837	Seed	5286909	6307032	3501568	4652948

Access funding benchmarks and valuations. Sign up today!

View details of microMend's funding rounds and investors

microMend's employee count trend

microMend has 11 employees as of Aug 26. Here is microMend's employee count trend over the years:

Uncover microMend's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of microMend include Kerecis, Aroa Biosurgery and Biolife. Here is the list of Top 10 competitors of microMend, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kerecis 2007, Isafjordur (Iceland), Acquired	Provider of fish-skin acellular dermal matrix transplantation technology	$93.1M	KIRKBI A/S, Emerson Collective & 5 others	61/100
2nd	Aroa Biosurgery 2008, Mangere (New Zealand), Public	Developer of medical and surgical products for soft tissue reconstruction	-	Alium Capital, Cure Kids Ventures & 2 others	51/100
3rd	Biolife 1999, Sarasota (United States), Acquired	Provider of products to stop bleeding and first-aid treatment	-	-	47/100
4th	Kitotech Medical 2011, Seattle (United States), Series A	Developer of a device to close wounds, lacerations, and surgical incisions	$21.2M	TiE, Kyto Technology & Life Science & 9 others	46/100
5th	Futura Medtech 1994, Bengaluru (India), Series B	Manufacturer of surgical wound closure products and medical device solutions	$25M	Jashvik Capital & 3 others	45/100
6th	microMend 2017, Seattle (United States), Series B	Provider of solutions for the treatment of dermatological disorders	$3.41M	Denniston Family Office, Michigan Capital Network ... & 3 others	39/100
7th	ACell 1999, Lafayette (United States), Acquired	Develops wound management devices using ECM technology	$8.7M	-	36/100
8th	PolyNovo 2004, Port Melbourne (Australia), Public	Developer of biodegradable temporising matrix for treating traumatic wounds	-	ELM Responsible Investments, Victorian Early Childhood Regulatory Authority ... & 1 others	36/100
9th	Medicud 2020, Romana (Italy), Seed	Developer of a medical device to treat exuding wounds	$1.95M	50 Partners, Les Business Angels des Grandes Écoles ... & 2 others	33/100
10th	Curiato 2014, Waterloo (Canada), Seed	Developer of pressure redistribution mattress and ulcer management platform	$30K	Accelerator Centre, Velocity & 2 others	33/100